查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470828

腫瘤消融市場：依技術、治療、適應症分類 - 2024-2030 年全球預測

Tumor Ablation Market by Technology (Cryoablation, High-Intensity Focused Ultrasound, Irreversible Electroporation Ablation), Treatment (Laparoscopic Ablation, Percutaneous Ablation, Surgical Ablation), Indication - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年腫瘤消融市場規模為17.8億美元，預計2024年將達20.1億美元，2030年將達44.2億美元，複合年成長率為13.85%。

腫瘤消融是一種微創外科手術，用於治療體內各器官的腫瘤。這種治療方法直接在腫瘤上使用熱、冷或化學製劑來破壞癌細胞，而不需要大切口。常用於治療肝癌、腎癌、骨癌、肺癌等。然而，這種技術對於大型腫瘤或靠近重要結構或器官的腫瘤並不總是有效，因為存在損壞這些區域的風險。此外，還可能發生出血、感染和周圍組織損傷等併發症。需要繼續研究來解決這些問題，包括提高消融技術的精度、開發更好的成像技術來指導手術以及加強對進行消融的醫療保健專業人員的培訓。人工智慧和機器學習的進步可能會提高消融手術的準確性和結果。此外，全球癌症盛行率的不斷上升以及對微創治療的需求不斷增加可能會推動腫瘤消融的採用。

主要市場統計
基準年[2023] 17.8億美元
預測年份 [2024] 20.1億美元
預測年份 [2030] 44.2億美元
複合年成長率（%） 13.85%

腹腔鏡消融術對需要治療性微創手術的患者的快速利用

腹腔鏡消融採用微創方法，使用射頻、微波和雷射等多種能源來源，透過皮膚上的小切口進入並摧毀腫瘤。這種方法是需要更快恢復和侵入性較小的選擇的患者的首選。當治療中小型腫瘤以及需要精確應用消融能量時，它特別有利。經皮切除術涉及在電腦斷層掃描或超音波等影像技術的引導下，將針頭穿過皮膚直接插入腫瘤。最常見的類型是射頻 (RF) 消融和微波消融。對於手術或腹腔鏡檢查難以觸及腫瘤的患者，或不適合進行開放性手術的患者，此方法為首選。經皮方法是微創的，通常比傳統手術需要更短的住院時間和更少的疼痛。手術切除術涉及透過開放性手術切除腫瘤，然後應用消融技術去除剩餘的癌細胞。此方法主要用於腫瘤較大或位於其他方法難以切除的位置時。當完全切除腫瘤是可能且理想時，首選手術切除，並且當腫瘤被隔離且可觸及時提供治癒的可能性。當由於腫瘤的大小或位置而無法使用腹腔鏡或經皮方法時，也可以選擇此方法。

適應症：加強腫瘤消融治療肺癌的研究

腫瘤消融，特別是冷凍，在治療小型早期乳癌方面已顯示出前景。這種方法是傳統手術的一種侵入性較小的治療方法，可以減少恢復時間和美容影響。然而，其應用通常僅限於小腫瘤，其與標準乳癌手術相比的長期療效仍在研究中。持續的臨床試驗對於更好地了解腫瘤消融在乳癌治療中的治療結果和潛在作用至關重要。射頻消融（RFA）和冷凍消融等腫瘤消融方法可有效用於治療較小的腎臟腫塊。這些方法對於因其他健康問題而不適合手術或腫瘤較小且局部的患者特別有益。腫瘤消融在原發性和續發性肝癌的治療上有明確的作用。 RFA 和微波消融 (MWA) 等技術很常用，特別是在無法進行手術切除的情況下。這些方法可有效實現局部腫瘤控制，提供潛在的生存益處，並且具有良好的安全性。腫瘤消融，特別是 RFA、冷凍消融和 MWA 的使用，正在成為非小細胞肺癌 (NSCLC) 的一種治療選擇。這些技術為治療早期肺癌和其他原發部位肺部轉移提供了一種微創方法。腫瘤消融在局部前列腺癌的治療中越來越受到關注，冷凍消融和聚焦雷射消熔（FLA）等方法正在研究中。這些技術提供了一種有針對性的方法，旨在減少與傳統治療方法（如前列腺切除術和放射線治療）相關的副作用，特別是尿失禁和勃起功能障礙。選擇前列腺癌腫瘤消融患者需要仔細考慮腫瘤的大小、位置和侵襲性。

區域洞察

在強大的醫療基礎設施和有利的報銷政策的支持下，美洲先進腫瘤消融技術的採用率很高。該地區是開發和製造尖端消融設備的主要公司的所在地，為全球市場佔有率做出了重大貢獻。在亞太地區，由於醫療成本上升、癌症發生率上升以及患者和醫療保健提供者對微創治療的認知不斷提高，腫瘤消融的使用正在迅速增加。儘管亞太地區的產能正在擴大，但該市場仍處於追趕西方市場普及的技術和監管標準的過程中。儘管一些本土公司正在崛起，但該市場對尋求擴大地域影響力的全球公司也具有吸引力。歐洲、中東和非洲地區場景多樣，西歐先進的醫療保健系統為腫瘤消融技術的採用提供了堅實的基礎，這體現在堅實的法律規範上。在歐洲、中東和非洲地區營運的公司包括跨國公司和當地小型企業，它們在複雜的監管和市場條件下提供腫瘤消融療法。

FPNV定位矩陣

FPNV定位矩陣對於評估腫瘤消融市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對腫瘤消融市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.腫瘤消融市場的市場規模和預測是多少？

2.在腫瘤消融市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.腫瘤消融市場的技術趨勢和法規結構是什麼？

4.腫瘤消融市場主要廠商的市場佔有率如何？

5.進入腫瘤消融市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症發生率上升以及有效治療方法的需求
      • 擴大轉向微創手術切除腫瘤
      • 完善晚期癌症治療的報銷政策
    • 抑制因素
      • 腫瘤消融裝置設計的複雜性
    • 機會
      • 全球腫瘤消融技術進展
      • 政府對腫瘤消融的有利核准
    • 任務
      • 對設備品質和安全的擔憂
  • 市場區隔分析
    • 治療：對需要微創手術的患者快速普及腹腔鏡消融術
    • 適應症：加強使用腫瘤消融治療肺癌的研究
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章腫瘤消融市場：依技術分類

  • 冷凍療法
  • 高強度聚焦超音波
  • 不可逆電穿孔消融
  • 雷射組織內熱消融
  • 微波消融
  • 射頻消融術

第7章依治療方式分類的腫瘤消融市場

  • 腹腔鏡消融術
  • 經皮消融術
  • 手術消融

第8章按適應症分類的腫瘤消融市場

  • 乳癌
  • 腎癌
  • 肝癌
  • 肺癌
  • 攝護腺癌

第9章美洲腫瘤消融市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太腫瘤消融市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲腫瘤消融市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Medtronic)利用 FDA核准的OsteoCool 2.0 系統改善骨腫瘤治療
    • BioTraceIO 基於超音波的 BioTraceIO 獲得 FDA核准
    • FDA 授予 Francis Medical, Inc. 的蒸汽消融療法 Vanquish 突破性稱號
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-03252A5F927F

[180 Pages Report] The Tumor Ablation Market size was estimated at USD 1.78 billion in 2023 and expected to reach USD 2.01 billion in 2024, at a CAGR 13.85% to reach USD 4.42 billion by 2030.

Tumor ablation is a minimally invasive surgical method used for the treatment of tumors within various organs of the body. This procedure involves directing heat, cold, or chemical agents directly into a tumor to destroy cancer cells without necessitating large incisions. It is commonly employed in the treatment of liver, kidney, bone, and lung cancers, among others. However, the technique may not always be effective for larger tumors or for tumors that are close to critical structures or organs, as there is a risk of damaging these areas. Additionally, there may be complications such as bleeding, infection, or damage to the surrounding tissues. Addressing these concerns involves ongoing research into improving the precision of ablation techniques, developing better imaging technology to guide the procedures, and enhancing the training of medical professionals performing ablations. Advances in artificial intelligence and machine learning could lead to improved precision and outcomes of ablation procedures. Furthermore, the increasing prevalence of cancer worldwide and the rising demand for minimally invasive treatments are likely to drive the adoption of tumor ablation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.78 billion
Estimated Year [2024] USD 2.01 billion
Forecast Year [2030] USD 4.42 billion
CAGR (%) 13.85%

Treatment: Exponential use of laparoscopic ablation for patients requiring minimally invasive surgery

Laparoscopic ablation involves the use of minimally invasive methods to access and destroy tumors using various energy sources, such as radiofrequency, microwave, or laser, through small incisions in the skin. This method is preferred for patients who require a minimally invasive option with a quicker recovery time. It is particularly advantageous for treating small to medium-sized tumors and where a precise application of ablation energy is needed. Percutaneous ablation involves the insertion of needles through the skin directly into the tumor, guided by imaging techniques such as CT scans or ultrasound. The most common types include radiofrequency (RF) ablation and microwave ablation. This approach is preferred for patients with tumors in locations difficult to reach by surgery or laparoscopy or who are not candidates for open surgery. The percutaneous method is minimally invasive and usually involves a shorter hospital stay and less pain compared to traditional surgery. Surgical Ablation entails the removal of the tumor through open surgery, followed by the application of ablation techniques to eliminate any remaining cancer cells. This method is primarily used for larger tumors or when tumors are located in positions that make other forms of ablation challenging. Surgical ablation is preferred when complete tumor resection is possible and desirable, offering a potential cure in cases where tumors are isolated and accessible. It is also chosen in situations where laparoscopic or percutaneous methods are not feasible due to the size or location of the tumor.

Indication: Increasing research in using tumor ablation for treating lung cancer

Tumor ablation, particularly cryoablation, has shown promise in the treatment of small, early-stage breast cancers. This method offers a less invasive alternative to traditional surgery, potentially reducing recovery times and cosmetic impact. However, its application is usually limited to small tumors, and the long-term efficacy compared to standard breast cancer surgeries is still under research. Ongoing clinical trials are essential to better understand the outcomes and potential roles of tumor ablation in breast cancer treatment. For small renal masses, tumor ablation techniques such as radiofrequency ablation (RFA) and cryoablation have been effectively used. These methods are particularly beneficial for patients who are not suitable for surgery due to other health concerns or for those with small, localized tumors. Tumor ablation has a well-established role in the management of primary and secondary liver cancers. Techniques such as RFA and microwave ablation (MWA) are commonly used, especially in cases where surgical resection is not possible. These methods can be effective in achieving local tumor control, offer potential survival benefits, and have a favorable safety profile. The use of tumor ablation, specifically RFA, cryoablation, and MWA, is emerging as a treatment option for non-small cell lung cancer (NSCLC). These techniques offer a minimally invasive approach to manage early-stage lung cancers or metastases to the lungs from other primary sites. Tumor ablation is gaining interest in the treatment of localized prostate cancer, with methods such as cryoablation and focal laser ablation (FLA) being explored. These techniques provide a targeted approach that aims to reduce side effects associated with more traditional treatments like prostatectomy and radiation therapy, particularly incontinence and erectile dysfunction. The selection of patients for tumor ablation in prostate cancer requires careful consideration of tumor size, location, and aggressiveness.

Regional Insights

In the Americas, there is a high adoption rate of advanced tumor ablation technologies, supported by strong healthcare infrastructure and favorable reimbursement policies. The region is home to leading companies that develop and manufacture cutting-edge ablation devices, contributing significantly to the global market share. The APAC region is witnessing rapid growth in the use of tumor ablation, driven by increasing healthcare expenditure, rising cancer prevalence, and growing awareness of minimally invasive treatments among patients and healthcare providers. Although APAC's production capabilities are expanding, the market is still in the process of catching up to the technical and regulatory standards prevalent in Western markets. Several local players are emerging, but the market is also attractive for global companies looking to expand their geographic presence. EMEA presents a diverse scenario where advanced healthcare systems in Western Europe offer a solid ground for the adoption of tumor ablation technologies mirrored by robust regulatory frameworks. Companies operating in the EMEA region are a mix of established global players and smaller, region-specific companies navigating the complex regulatory and market landscape to ensure the availability of tumor ablation therapies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tumor Ablation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tumor Ablation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tumor Ablation Market, highlighting leading vendors and their innovative profiles. These include Angiodynamics, Inc., Bioventus LLC., Boston Scientific Corp., BVM Medical Limited, Chongqing Haifu Medical Technology Co., Ltd., CONMED Corporation, CooperSurgical, Inc., Erbe Elektromedizin GmbH, IceCure Medical Ltd., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Mermaid Medical A / S, Smith & Nephew PLC, and Theraclion S. A..

Market Segmentation & Coverage

This research report categorizes the Tumor Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Cryoablation
    • High-Intensity Focused Ultrasound
    • Irreversible Electroporation Ablation
    • Laser Interstitial Thermal Ablation
    • Microwave Ablation
    • Radiofrequency Ablation
  • Treatment
    • Laparoscopic Ablation
    • Percutaneous Ablation
    • Surgical Ablation
  • Indication
    • Breast Cancer
    • Kidney Cancer
    • Liver Cancer
    • Lung Cancer
    • Prostate Cancer
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Tumor Ablation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tumor Ablation Market?

3. What are the technology trends and regulatory frameworks in the Tumor Ablation Market?

4. What is the market share of the leading vendors in the Tumor Ablation Market?

5. Which modes and strategic moves are suitable for entering the Tumor Ablation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer and need for effective treatments
      • 5.1.1.2. Increasing shift to minimally invasive surgeries to remove tumors
      • 5.1.1.3. Improvements in reimbursement policies for advanced cancer treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity of designing tumor ablation devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in tumor ablation technologies worldwide
      • 5.1.3.2. Favorable government approvals for tumor ablation
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with quality and safety of the device
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Treatment: Exponential use of laparoscopic ablation for patients requiring minimally invasive surgery
    • 5.2.2. Indication: Increasing research in using tumor ablation for treating lung cancer
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Tumor Ablation Market, by Technology

  • 6.1. Introduction
  • 6.2. Cryoablation
  • 6.3. High-Intensity Focused Ultrasound
  • 6.4. Irreversible Electroporation Ablation
  • 6.5. Laser Interstitial Thermal Ablation
  • 6.6. Microwave Ablation
  • 6.7. Radiofrequency Ablation

7. Tumor Ablation Market, by Treatment

  • 7.1. Introduction
  • 7.2. Laparoscopic Ablation
  • 7.3. Percutaneous Ablation
  • 7.4. Surgical Ablation

8. Tumor Ablation Market, by Indication

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Kidney Cancer
  • 8.4. Liver Cancer
  • 8.5. Lung Cancer
  • 8.6. Prostate Cancer

9. Americas Tumor Ablation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tumor Ablation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tumor Ablation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Medtronic Elevates Bone Tumor Treatment with FDA-Approved OsteoCool 2.0 System
    • 12.3.2. BioTraceIO receives FDA Approval for Ultrasound-Based BioTraceIO
    • 12.3.3. FDA Grants Breakthrough Designation to Vanquish Water Vapor Ablation Therapy by Francis Medical, Inc.
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. TUMOR ABLATION MARKET RESEARCH PROCESS
  • FIGURE 2. TUMOR ABLATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TUMOR ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. TUMOR ABLATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. TUMOR ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TUMOR ABLATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TUMOR ABLATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL TUMOR ABLATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL TUMOR ABLATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL TUMOR ABLATION MARKET SIZE, BY IRREVERSIBLE ELECTROPORATION ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL TUMOR ABLATION MARKET SIZE, BY IRREVERSIBLE ELECTROPORATION ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL TUMOR ABLATION MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL TUMOR ABLATION MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL TUMOR ABLATION MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL TUMOR ABLATION MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. AUSTRALIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 99. CHINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. CHINA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 105. INDIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 111. INDONESIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. INDONESIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 117. JAPAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. JAPAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 123. MALAYSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. MALAYSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. PHILIPPINES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 135. SINGAPORE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. SINGAPORE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. SOUTH KOREA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 147. TAIWAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. TAIWAN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 153. THAILAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. THAILAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 159. VIETNAM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. VIETNAM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA TUMOR ABLATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 173. DENMARK TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. DENMARK TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 179. EGYPT TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. EGYPT TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 185. FINLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. FINLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 191. FRANCE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. FRANCE TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 197. GERMANY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. GERMANY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 203. ISRAEL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. ISRAEL TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 209. ITALY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. ITALY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NETHERLANDS TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 221. NIGERIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. NIGERIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 227. NORWAY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. NORWAY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 233. POLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. POLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 239. QATAR TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 240. QATAR TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 245. RUSSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. RUSSIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SAUDI ARABIA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH AFRICA TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 263. SPAIN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SPAIN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 269. SWEDEN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWEDEN TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. SWITZERLAND TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 281. TURKEY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. TURKEY TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED KINGDOM TUMOR ABLATION MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 295. TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 296. TUMOR ABLATION MARKET, FPNV POSITIONING MATRIX, 2023